Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million ...
Qiagen (QGEN) announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a provider of scalable, instrument-free ...